[Renal cell carcinoma (hypernephroid carcinoma)].
Our own 215 patients who were operated on for renal cell carcinoma in a period of 10 years are examined, statistically established and the treatment performed is described. The 5-year survival rate of 58% of the curatively operated patients as well as the primary operation mortality of 1.4% are at the top. This is remarkable for that reason since we in our department our department are not fixed at the at present generally propagated transperitoneal approach in the tumour nephrectomy. We individually choose the operative approach according to location and size of the tumour. Apart from this we perform the removal of the regional lymphatic glands only when there is a suspicion of metastases. So the authors think that at present an improvement of the results is not so much to be seen in the choice of the operative approach but in the early recognition of the tumor by routine sonographies of the kidneys.
D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009392:Nephrectomy
Zur Frage des Nierenzellkarzinoms (hypernephroiden Karzinoms).